Identification of the sentinel lymph node stained with blue dye in breast cancer patients

Purpose: This study aimed to evaluate the reproducibility of sentinel lymphadenectomy in breast cancer patients (T1N0M0 and T2N0M0) and its possibility of predicting the total axillary behavior.

Methods: A total of 25 patients were evaluated, all presenting palpable mammary nodes between 1.5 and 5 cm (T1 and T2), with clinically negative axillary lymph nodes (N0). After an incisional biopsy of the tumor and histopathological confirmation of invasive breast carcinoma, a study of the sentinel lymph node took place with a peritumoral injection of 4 ml of blue dye at 2.5%. After waiting for 15 to 20 minutes, a search for the blue stained lymphatic vase in the axillary fat was carried out, which would lead to the sentinel lymph node, stained or not. At that point, a mastectomy (20 patients) or a quadrantectomy (5 patients) was performed, both with axillary lymphadenectomy at grades 1, 2 and 3. The sentinel lymph nodes and the material from the axillary dissection were sent separately for an anatomicopathological test in paraffin.

Results: The lymph nodes were identified in 19 patients, which represented a 76% detection rate. There was a concordance between the sentinel lymphadenectomy and the standard axillary dissection in 68.4% of the patients. The false-positive and the false-negative rates observed were 10% and 55.5%, respectively. A higher detection rate was found in tumors larger than 2 cm and situated in external quadrants.

Conclusions: Sentinel lymphadenectomy identified the sentinel lymph node in the majority of the patients in this study, although the high rate of false-negatives observed prevented an accurate staging.

Sentinel lymph node; Breast cancer; Blue dye

[1] McIntosh S.A., Purushotham A.O.: "Lymphatic mapping and sentinel node biopsy in breast cancer". Brit. J. Surg., 1998, 85, 1347.

[2] McMasters K.M., Giuliano A.E., Ross M.I., Reintgen D.S., Hunt K.K., Byrd D.R. et al: "Sentinel lymph node biopsy for breast cancer - not yet the standard of care". N. Engl. J. Med., 1998, 339, 990.

[3] Krag D.N., Weaver D., Ashikaga T., Moffat F., Klimberg V.S., Shriver C. et al.: "T he sentinel node in breast cancer. A multicenter validation study". N. Engl. J. Med., 1998, 339, 941.

[4] Giuliano A.E., Kirgan D.M., G uenther J.M., Morton D.L.: "Lymphatic mapping and sentinel lymphadenectomy for breast cancer". Ann. Surg., 1994, 220, 391.

[5] Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M. et al.: "Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes". Lancet, 1997, 349, 1864.

[6] Giuliano A.E., Barth A.M., Spivak B., Beitsch P.O., Evans S.W.: "Incidence and predictors of axillary metastasis in T 1 carcinoma of the breast". J. Am. Coll. Surg., 1996, 183, 185.

[7] Borgstein P., Meijer S.: "Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept". Eur. J. Surg. Oneal., 1998, 24, 85.

[8] Krag D.N.: "Minimal acess surgery for staging regional lymph nodes: The sentinel node concept". Curr. Prob/. Surg., 1998, 35, 951.

[9] Veronesi U., Luini A., Galimberti V., Marchini S., Sacchini V., Rilke F.: "Extent of metastatic axillary involvement in 1447 cases of breast cancer". Eur. J. Surg. Oneal., 1990, 16, 127.

[10] Borgstein P.J., Meijer S., Pijpers R.: "Intradermal blue dye to identify sentinel lymph node in breast cancer". Lancet, 1997, 349, 1668.

[11] Giuliano A.E., Jones R.C., Brennan M., Statman R.: "Sentinel lymphadenectomy in breast cancer". J. Clin. Oneal., 1997, 15, 2345.

[12] Hsueh E.C., Giuliano A.E.: "Sentinel lymph node technique for staging of breast cancer". Oncologist, 1998, 3, 165.

[13] Guenther J.M., Krishnamoorthy M., Tan L.R.: "Sentinel lymphadenectomy for breast cancer in a community managed care setting". Cancer J. Sci. Am., 1997, 3, 336.

[14] Flett M.M., Going J.J., Stanton P.D., Cooke T.G.: "Sentinel node localization in patients with breast cancer". Br. J. Surg., 1998, 85, 991.

[15] O'Hea B.J., Hill A.D.K., El-Shirbiny A. M., Yeh S.D.J., Rosen P.P., Coit D.G.: "Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center". J. Am. Coll. Surg., 1998, 186, 423.

[16] Tome A., Iglesias X.: "Sentinel-node biopsy in breast cancer". Lancet, 1997, 350, 808.

[17] Veronesi U., Zurrida S., Galimberti V.: "Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies". Eur. J. Surg. Oneal., 1998, 24, 93.